| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
4 companies
Freund John Gordon is a Director at TARA with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $15.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | COLL Collegium Pharmaceutical, Inc | Director | Sell | 11,659 | $34.36 | $400,640.55 | -33.5% | +16.4% | - | |
| Aug 8, 2025 | SIBN Si-Bone, Inc. | Director | Sell | 12,132 | $15.99 | $193,997.96 | -11.7% | -3.1% | - | |
| Jun 9, 2025 | COLL Collegium Pharmaceutical, Inc | Director | Sale+OE | 6,601 | $30.62 | $202,149.02 | -8.5% | +24.0% | - | |
| Aug 9, 2023 | SIBN Si-Bone, Inc. | Director | Sell | 30,000 | $20.54 | $616,197.00 | -22.4% | -15.3% | -29.6% | |
| Jun 16, 2021 | SIBN Si-Bone, Inc. | Director | Sell | 52,092 | $31.24 | $1,627,300.87 | -4.8% | -29.8% | -59.7% | |
| May 28, 2021 | SIBN Si-Bone, Inc. | Director | Sell | 71,587 | $30.38 | $2,174,967.74 | -8.1% | -23.6% | -52.4% | |
| May 26, 2021 | SIBN Si-Bone, Inc. | Director | Sell | 69,861 | $32.37 | $2,261,538.29 | -3.6% | -30.7% | -55.4% | |
| Mar 17, 2021 | SIBN Si-Bone, Inc. | Director | Sell | 721,253 | $30.38 | $21,913,571.65 | -20.2% | -3.0% | -36.3% | |
| Mar 15, 2021 | SIBN Si-Bone, Inc. | Director | Sell | 235,887 | $31.13 | $7,343,186.27 | -5.6% | +0.7% | -38.3% | |
| Dec 3, 2020 | SIBN Si-Bone, Inc. | Director | Sell | 147,886 | $23.32 | $3,448,677.20 | -4.7% | - | - |